MedTrace Logo

MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research

NCT02313623 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2026-02-12

No results posted yet for this study

Summary

The investigators hypothesize that this single-cell analysis can be used to evaluate prostate needle-core biopsies prospectively even in non-homogenous samples by providing profiles of proteomic and phenotypic signatures. These profiles will in turn enable better predictions of the malignant progression of prostate cancers in the settings of current clinical practice.

Conditions

Interventions

PROCEDURE

Prostate Fusion Biopsy

For subjects with scheduled fusion biopsies, we propose a research plan to acquire additional biopsy cores for research purposes without impacting clinical protocol. After acquiring clinically-necessary biopsies, we propose taking an additional research biopsy to establish a matched-pair of clinical and research samples.

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Preston C Sprenkle, MD · Yale University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2025-10-01
Completion
2025-10-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02313623 on ClinicalTrials.gov